百花医药龙虎榜：营业部净卖出1864.45万元

Core Viewpoint - Baihua Pharmaceutical (600721) experienced a significant drop, reaching the daily limit down, with a trading volume of 262 million yuan and a turnover rate of 6.85% [2] Group 1: Stock Performance - The stock's price fell by 9.91%, leading to its inclusion on the Shanghai Stock Exchange's watch list for significant price deviation [2] - Over the past six months, the stock has appeared on the watch list five times, with an average price drop of 2.37% the day after being listed and an average decline of 4.10% over the following five days [3] Group 2: Trading Activity - The net selling amount from brokerage seats totaled 18.64 million yuan, with the top buying brokerage being Zhongshan Securities, which purchased 4.96 million yuan worth of shares, while the top selling brokerage was China Galaxy Securities, selling 10.19 million yuan [2][3] - The stock saw a net outflow of 74.48 million yuan in principal funds today, with large orders contributing to a net outflow of 58.93 million yuan and 15.55 million yuan from larger orders [3] Group 3: Financial Performance - For the first three quarters of 2025, Baihua Pharmaceutical reported a revenue of 299 million yuan, reflecting a year-on-year growth of 2.74%, and a net profit of 32.67 million yuan, which is a 36.41% increase compared to the previous year [3]